Tuesday, November 2, 2021

Fresenius Kabi recalls hospital sedative on accidental mix with lidocaine—again


In hospital settings, powerful anesthetics are often reserved for the most critical procedures, and it’s important that they work exactly as intended. But Fresenius Kabi slipped on a major banana peel earlier this year when it found samples of one of its sedatives mixed with lidocaine—and now the drugmaker is having déjà vu.

Fresenius Kabi recalled one lot of injectable dexmedetomidine hydrochloride, a powerful sedative used to put and keep patients under during surgery, after the company found lidocaine cross-contamination in test samples, the FDA said Thursday.

Lidocaine, a local anesthetic, can cause severe allergic reactions in certain patients, but Fresenius Kabi said it has yet to receive a side-effect report from the recalled lot.

Whitepaper

The Rise of HPAPI Molecules – Trends in Highly Potent API Manufacturing

Highly potent active pharmaceutical ingredients are increasing in pharma pipelines. Lonza offers all HPAPI-related expertise to support your product development from concept to commercial use in an integrated manner.

The market pull affects a lot distributed between April 9 and April 13 with an expiration date of March 2022. 

RELATED: Fresenius Kabi recalls 2 lots of scarce ICU sedative over potential lidocaine contamination

It’s a serious mix-up and not the first time Fresenius Kabi has been forced to pull the exact same drug off the market on cross-contamination woes. 

In July, the German generics maker recalled two lots of injectable dexmedetomidine HCl after investigations alerted the drugmaker to potential traces of lidocaine. Those lots were distributed between June 2019 and April, according to the FDA’s recall listing. 

Dexmedetomidine HCl is not approved for patients who have been intubated, limiting its use in severe COVID-19 patients. Since the pandemic began, U.S. hospitals have seen chronic shortages of sedatives and other drugs used to treat those patients, who sometimes require respirators.

RELATED: Fresenius Kabi recalls anti-inflammation drug Ketorolac after finding particles in vials



Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...